INITIATOR PHARMA: Q1 2022 REPORT

Business highlights in Q1 2022 On January 20th the initiation of dosing in the IPTN2021 program Phase 1 to assess pain reducing effects in healthy volunteers was announced. On March 22nd it was…

INTERIM REPORT JANUARY- JUNE 2021

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016. Second…

INTERIM REPORT JANUARY- MARCH 2021

Business highlights in Q1 2021 On January 14[th] the EGM approved the proposed convertible financing agreement with MAC Clinical Research, covering up to SEK 23 million (approx. DKK 17 million) of…